RIVOTRIL® (clonazepam)

  • ACTIVE SUBSTANCE: clonazepam
  • CONCENTRATION: 0,25 mg, 0,5 mg, 2 mg e 2,5 mg
  • PRESENTATION: 20 or 30 individual tablets / Bottle with 20 ml / Sublingual tablet
  • MARKETING: Biopas
  • Customer Service: Biopas 0800 591 9210


Adults and children.

Epileptic disorder.

Rivotril® is indicated for the treatment of epileptic seizures and infantile spasm (West syndrome).


Rivotril® is also indicated for:

Anxious disorders

  • As an anxiolytic in general.
  • Panic disorder with or without fear of open spaces.
  • Social phobia (fear of situations such as public speaking).

Mood swings

  • Bipolar affective disorder (periods of depression and mania): treatment of mania.
  • Major depression: associated with antidepressants in anxious depression and treatment initiation.

Psychotic syndromes

  • Akathisia (extreme restlessness, usually caused by psychiatric medications).

Restless legs syndrome (discomfort or pain in the legs that causes them to need to be moved and interferes with sleep).

  • Dizziness and balance problems: nausea, vomiting, fainting, falls, tinnitus, and hearing problems. Burning mouth syndrome (burning sensation inside the mouth without physical changes).


Rivotril® is contraindicated in patients with known hypersensitivity to clonazepam or any of the excipients of the drug and in patients with severe respiratory insufficiency or severe liver involvement, since benzodiazepines can lead to nervous system involvement secondary to liver disease.

Rivotril® tablets and Rivotril® drops are contraindicated for the treatment of panic disorder in patients with a history of sleep apnea.

Rivotril® is contraindicated in patients with acute angle-closure glaucoma. Rivotril® can be used in patients with open-angle glaucoma provided they are receiving appropriate treatment.


Rua Joaquim Faustino de Camargo, 201, Jardim São Paulo, Taboão da Serra - SP (11) 4138-8200 • © Blanver 2020, Todos os direitos reservados